Prolotherapy 3

State of the Art Prolotherapy Theatre

Prolotherapy 1

Sclerosant Injections to Ligaments

Prolotherapy 2

Reduces the Risk of Recurring Back Pain

Prolotherapy 4

Neural Prolotherapy

Prolotherapy Research

A recent study of the compensation cases of over 725 workers who underwent spinal fusion discovered that 36% had surgical complications and 27% needed a second operation. After 2 years only 26% had returned to work, compared to 67% of controls. 76% continued opiate use after surgery, while mean opiate use increased by 41% (Nguyen T et al. Spine, 2010). Analgesic related mortality after lumbar fusion in workers’ compensation cases has been shown to be as much as 1% (Juratli SM et al. Spine, 2009). It has been demonstrated that 2 years after surgery in a study of workers’ compensation cases, 63.9% of patients were disabled, and the re-operation rate was 22% (Juratli SM et al. Spine, 2006).

“Lumbar fusion surgery for disc degeneration, disc herniation and/or radiculopathy in a workers’ compensation setting is associated with significant increase in disability, opiate use, prolonged work loss and poor return-to-work status” (Conclusion by Nguyen et al. Spine, 2010).


Whilst further good quality research may still be required, prolotherapy is a safe and useful technique in the management of certain spinal pain syndromes. It should be considered before resorting to fusion or disc replacement in view of its minimally invasive nature, cost-effectiveness and the low incidence of adverse reactions or consequent disability compared to surgery.

Keep reading for comments on individual research